Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
about
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyMitochondria, cholesterol and cancer cell metabolismTargets for therapy in sarcomeric cardiomyopathiesNRF2 Is a Key Target for Prevention of Noise-Induced Hearing Loss by Reducing Oxidative Damage of Cochlea.Different Contribution of Redox-Sensitive Transient Receptor Potential Channels to Acetaminophen-Induced Death of Human Hepatoma Cell Line.The complexity of the Nrf2 pathway: beyond the antioxidant responseMechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid estersCytoprotection "gone astray": Nrf2 and its role in cancerThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersDimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitisα-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.The succinated proteome.Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanismsThe role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney.Succinate metabolism: a new therapeutic target for myocardial reperfusion injury.Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1α and Nrf2.Dimethyl fumarate ameliorates acute pancreatitis in rodent.Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-induced Nephrotoxicity.Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart FailureDimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway.Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusionProtective Effects of L-Malate against Myocardial Ischemia/Reperfusion Injury in RatsEffects of perhexiline-induced fuel switch on the cardiac proteome and metabolome.Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity.The emerging role of the Nrf2-Keap1 signaling pathway in cancerConnexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model.Changing appetites: the adaptive advantages of fuel choice.Nrf2 and cardiovascular defense.Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases.Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisHeme oxygenase-1: an emerging therapeutic target to curb cardiac pathology.Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylation.Protection effect of nicotinamide on cardiomyoblast hypoxia/re-oxygenation injury: study of cellular mitochondrial metabolism.Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression.
P2860
Q26738969-6B285831-6E68-46E4-9156-903DE1A08519Q26741708-89E5F786-4587-4800-AD0C-012E557BA16CQ27027023-9AF78853-651D-4644-B1C2-47FB9EE6FD81Q27301747-6FEEF0C3-136E-475D-B6F4-2760C244F8F7Q27308057-0DD55C06-E394-4BFA-A22A-749447B45B93Q28389296-263AB947-E345-421B-8A27-7CF8ACD25615Q28389828-AA7826EB-D370-45E7-A341-FE5891EB2688Q28393784-5C16AC49-34DC-4F7C-807E-53161618D18DQ28395641-85C5D4BD-8A60-4ACD-8DD3-FB2D7B6EF4FFQ28542872-087ADC82-3D69-4E94-99E2-79E4EBAC18C2Q30457378-83EC4D40-F691-442E-A11D-0CB33F39C821Q33684446-C08C2A8E-47B9-4C5E-B4C5-2C012EF7C027Q33702016-A6A77822-A20E-4E07-B0E0-561E661C5E6BQ33761211-38B82578-F64A-42E2-B244-6A45D69AD7C3Q33865212-49EE7E66-1C71-4D61-9FED-5D6FC3B26B4DQ33914944-05F18780-E240-40BA-A18D-A34826F4E7E7Q34447034-646FCD14-3325-4858-840F-50972BEB3DC4Q34448170-5481AA08-1CD3-4EB6-8A3F-77AEDC9AD3E5Q34527213-FF768BCF-83FE-4531-92BD-186221676BF9Q34737959-64BDE5B7-ECB7-4B2A-B566-277799E36D7EQ35009620-D4D0DF83-4FE3-497D-8933-2B67988C92C7Q35171216-D2D633B2-25B6-467C-98E3-E527E54ABC8FQ35674764-17690CD1-932A-4326-9A5F-2ACCA0121507Q35775155-B65464BE-6DC5-4892-94C9-03E361F19201Q35911773-8C16F17E-FBF3-4AAB-90BF-F5E2303DF289Q36393675-E051B0C1-8FFD-4643-BBC3-67DA5AF90776Q36578366-BB0A6A55-654E-4B33-82F6-D62B51C3993BQ36612080-5A8223D5-6AB5-4426-A4E7-213225070572Q37022039-7EF75253-8D39-4F6C-9222-6FED20FB4F93Q37065314-642C83E8-25DF-469C-8954-CA6A657DD8FCQ37271797-60B5C7F9-10D0-41FC-9D75-3583D77362A0Q37572134-2268726C-C064-4F86-A763-F2B729B96823Q37624803-769B5663-A8DC-44A8-942A-4036026EEB38Q38108306-E3AC901D-80EE-42AA-A757-2DC62B73FDF1Q38167610-DCD7273D-5321-4645-A8BB-8947D681FB1DQ38216015-CFBF3DE2-B7C8-4DCE-A529-EFD5A95A5C69Q38262595-B48D299D-89C8-42FC-AAE2-09B956892099Q38302272-0E5D90A2-2422-4185-B124-006E46BA13ACQ38772438-3AA43A8B-B4DA-4035-B271-AE4699003E9BQ38936140-10BE612D-DB53-489A-8A97-A29CD8CC5A7A
P2860
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
@ast
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
@en
type
label
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
@ast
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
@en
prefLabel
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
@ast
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
@en
P2093
P2860
P50
P1433
P1476
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway
@en
P2093
Alan J Robinson
Charles Redwood
Christian Ludwig
Daniel R Ball
Henrik Isackson
Hussain Contractor
Iain Hargreaves
Ismayil Ahmet
Jonathan J Byrne
P2860
P304
P356
10.1016/J.CMET.2012.01.017
P50
P577
2012-03-01T00:00:00Z